Growth hormone secretagogues stimulate the hypothalamic-pituitary- adrenal axis and are diabetogenic in the Zucker diabetic fatty rat

Endocrinology

Volumn 138, Issue 10, 1997, Pages 4316-4323

  Clark, R G ^a   Thomas, G B ^b   Mortensen, D L ^a   Won, W B ^a   Ma, Y H ^a   Tomlinson, E E ^a   Fairhall, K M ^b   Robinson, I C A F ^b  

^a GENENTECH INC   (United States)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; GROWTH HORMONE; HYDROCORTISONE;

ANIMAL EXPERIMENT; ARTICLE; CORTICOTROPIN RELEASE; DIABETES MELLITUS; DIABETOGENESIS; GLUCOSE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030967950     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.10.5424     Document Type: Article

References (39)

1. Bowers CY, Veeraragavan K, Sethumadhavan K 1994 Atypical growth hormone releasing peptides. In: Bercu BB, Walker RF (eds) Growth Hormone II: Basic and Clinical Aspects. Serono Symposia, New York, pp 203-222
2. Bowers CY, Momany F, Reynolds GA, Hong A 1984 On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114:1537-1545
3. Bowers CY, Reynolds GA, Durham D, Barrera CM, Pezzoli SS, Thorner MO 1990 Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab 70:975-982
4. Frieboes RM, Murck H, Maier P, Schier T, Holsboer F, Steiger A 1995 Growth hormone-releasing peptide-6 stimulates sleep, growth-hormone, ACTH and cortisol release in normal man. Neuroendocrinology 61:584-589
5. Hickey G, Jacks T, Judith F, Taylor J, Schoen WR, Krupa D, Cunningham P, Clark J, Smith RG 1994 Efficacy and specificity of I-692,429, a novel nonpeptidyl growth-hormone secretagogue, in beagles. Endocrinology 134:695-701
6. Gertz BJ, Sciberras DG, Yogendran L, Christie K, Bador K, Krupa D, Wittreich JM, James I 1994 L-692,429, a nonpeptide growth hormone (GH) secretagogue, reverses glucocorticoid suppression of GH secretion. J Clin Endocrinol Metab 79:745-749
7. Copinschi G, Van Onderbergen A, L'Hermite-baleriaux M, Mendel CM, Caufriez A, Leproult R, Bolognese JA, De Smet M, Thorner MO, Van Cauter E 1996 Effects of 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men. J Clin Endocrinol Metab 81:2776-2782
8. Saenger P 1996 Editorial: Oral growth hormone secretagogues - better than Alice in Wonderlands's growth elixir? J Clin Endocrinol Metab 81:2773-2775
9. Smith RG, Pong S-S, Hickey G, Jacks T, Cheng K, Leonard R, Cohen CJ, Arean JP, Chang CH, Drisko J, Wyvratt M, Fisher M, Nargund R, Pathcett A 1996 Modulation of pulsatile GH release through a novel receptor in hypothalamus and pituitary gland. Recent Prog Horm Res 51:261-286
10. McDowell RS, Elias KA, Stanley MS, Burdick DJ, Burnier JP, Chan KS, Fairbrother WJ, Hammonds RG, Ingle GS, Jacobsen NE, Mortensen DL, Rawson TE, Won WB, Clark RG, Somers TC 1995 Growth-hormone secretagogues - characterization, efficacy, and minimal bioactive conformation. Proc Natl Acad Sci USA 92:11165-11169
11. Elias KA, Ingle GS, Burnier JP, Hammonds RG, McDowell RS, Rawson TE, Somers TC, Stanley MS, Cronin MJ 1995 In vitro characterization of four novel classes of growth hormone-releasing peptide. Endocrinology 136:5694-5699
12. Zucker TF, Zucker LM 1962 Hereditary obesity in the rat associated with high serum fat and cholesterol. Proc Soc Exp Biol Med 110:165-171
13. Clark JB, Palmer CJ, Shaw WN 1983 The diabetic Zucker fatty rat. Proc Soc Exp Biol Med 173:68-75
14. Tokuyama Y, Sturis J, DePaoli AM, Takeda J, Stoffel M, Tang J, Sun X, Polonsky KS, Bell GI 1995 Evolution of β-cell dysfunction in the male Zucker diabetic fatty rat. Diabetes 44:1447-1457
15. Turkenkopf IJ, Kava RA, Feldweg A, Horowitz C, Greenwood MRC, Johnson PR 1991 Zucker and Wistar diabetic fatty rats show different responses to adrenalectomy. Am J Physiol 261:R912-R919
16. Clark RG, Chambers G, Lewin J, Robinson ICAF 1986 Automated repetitive microsampling of blood: growth hormone secretion in conscious male rats. J Endocrinol 111:27-35
17. Thomas GB, Fairhall KM, Robinson ICAF 1997 Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats. Endocrinology 138:1585-1591
18. Oster M, Fielder P, Levin N, Cronin MJ 1995 Adaptation of the growth hormone and insulin-like growth factor-I axis to chronic and severe calorie or protein malnutrition. J Clin Invest 95:2258-2265
19. Lee PD, Baker BK, Liu F, Kwan EY, Hintz RL 1996 A homologous radioimmunoassay for rat insulin-like growth factor-I (IGF-I): implications for studies of human IGF-I physiology. J Clin Endocrinol Metab 81:2002-2005
20. Kupfer SR, Underwood LE, Baxter RC, Clemmons DR 1993 Enhancement of the anabolic effects of growth hormone and insulin-like growth factor I by use of both agents simultaneously. J Clin Invest 91:391-396
21. Cheetham TD, Holly JM, Clayton K, Cwyfan-Hughes S, Dunger DB 1995 The effects of repeated daily recombinant human insulin-like growth factor I administration in adolescents with type 1 diabetes. Diabetes Med 12:885-892
22. Bercu BB, Yang SW, Masuda R, Hu C-S, Walker RF 1992 Effects of co-administered growth hormone (GH)-releasing hormone and GH-releasing hexapeptide on maladaptive aspects of obesity in Zucker rats. Endocrinology 131:2800-2804
23. Azain MJ, Roberts TJ, Martin RJ, Kasser TR 1995 Comparison of daily vs. continuous administration of somatotropin on growth rate, feed intake, and body composition in intact female rats. J Anim Sci 73:1019-1029
24. Scheiwiller E, Guler HP, Merryweather J, Scandella C, Maerki W, Zapf J, Froesch ER 1986 Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I. Nature 323:169-171
25. Robinson ICAF, Clark RG, Carlsson LMS 1987 Insulin, IGF-1 and growth in diabetic rats. Nature 326:549
26. Guler H, Zapf J, Scheiwiller E, Froesch E 1988 Recombinant human insulin-like growth factor 1 stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci USA 85:4889-4893
27. Clark R, Mortensen D, Carlsson L 1995 Insulin-like growth factor-I and growth hormone (GH) have distinct and overlapping anabolic effects in GH-deficient rats. Endocrine 3:297-304
28. Clark RG, Mortensen DL, Carlsson LMS, Carlsson B, Carmignac D, Robinson ICAF 1996 The obese growth hormone (GH)-deficient dwarf rat: body fat responses to patterned delivery of GH and insulin-like growth factor-I. Endocrinology 137:1904-1912
29. Dubuis J-M, Deal C, Tsagaroulis P, Clark R, van Vliet G 1996 Effects of 14-day infusions of growth hormone and or insulin-like growth factor 1 on the obesity of growing Zucker rats. Endocrinology 137:2799-2806
30. Bengtsson BA, Eden S, Lonn L, Kvist H, Stokland A, Lindstedt G, Bosaeus I, Tolli J, Sjostrom L, Isaksson OGP 1993 Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab 76:309-317
31. Laron Z, Klinger B 1993 Body fat in Laron syndrome patients: effect of insulin-like growth factor I treatment. Horm Res 40:16-22
32. Rosenblum CI, Tota M, Cully D, Smith T, Collum R, Qureshi S, Hess JF, Phillips MS, Hey PJ, Vongs A, Fong TM, Xu L, Chen HY, Smith RG, Schindler C, Van der Ploeg LHT 1996 Functional STAT 1 and 3 signaling by the leptin receptor (OB-R): reduced expression of the fat fatty leptin receptor in transfected cells. Endocrinology 137:5178-5181
33. Kostyo JL 1987 Diabetogenic effects of growth hormone. In: Issaksson O, Binder C, Hall K, Hokfelt B (eds) Growth Hormone: Basic and Clinical Aspects. Elsevier, Amsterdam, pp 217-225
34. Schleim K-D, Jacks T, Cunningham P, Feeney W, Frazier EG, Niebauer GW, Zhang D, Chen H, Smith RG, Hickey G, Effect of MK-677 on growth hormone, IGF-1 and cortisol in beagles before and after hypophysectomy. 10th International Congress of Endocrinology, San Francisco, CA, 1996
35. Hickey GJ, Drisko J, Faidley T, Chang C, Anderson LL, Nicolich S, McGuire L, Rickes E, Krupa D, Feeney W, Friscino B, Cunningham P, Frazier E, Chen H, Laroque P, Smith RG 1996 Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585. J Endocrinol 148:371-380
36. Clark RG, Carlsson L, Trojnar J, Robinson I 1989 The effects of a growth hormone-releasing peptide and growth hormone-releasing factor in conscious and anesthetized rats. J Neuroendocrinol 1:249-255
37. Howard AD, Feighner SD, Cully DF, Arena JP, Liberator PA, Rosenblum CI, Hamelin M, Hreniuk DL, Palyha OC, Anderson J, Paress PS, Diaz C, Chou M, Liu KK, McKee KK, Pong SS, Chaung LY, Elbrecht A, Dashkevicz M, Heavens R, Rigby M, Sirinathsinghji DJS, Dean DC, Melillo DG, Van der Ploeg LH 1996 A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273:974-977
38. Massoud AF, Hindmarsh PC, Matthews DR, Brook CG 1996 The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity. Clin Endocrinol (Oxf) 44:555-562
39. Chapman IM, Bach MA, Van Cauter E, Farmer M, Krupa D, Taylor AM, Schilling LM, Cole KY, Skiles EH, Pezzoli SS, Hartman ML, Veldhuis JD, Gormley GJ, Thorner MO 1996 Stimulation of the growth hormone (GH)-insulin-like growth factor I axis by daily oral administration of a GH secretogogue (MK-677) in healthy elderly subjects. J Clin Endocrinol Metab 81:4249-4257